Alexion To Present At The Bank Of America Merrill Lynch 2018 Health Care Conference

Tuesday, May 8, 2018 4:30 pm EDT NEW HAVEN, Conn.–(BUSINESS WIRE)–Alexion Pharmaceuticals (Nasdaq: ALXN) today announced that management will present at the Bank of America Merrill Lynch Health Care Conference in Las Vegas on Wednesday, May 16, 2018 at 2:20

Alexion To Acquire Wilson Therapeutics

 April 11, 2018 – WTX101 is in Phase 3 Development as a Novel Treatment for Wilson Disease, a Rare, Genetic, and Chronic Copper-Mediated Liver Disorder – – Conference Call and Webcast Scheduled for Today, April 11, 2018 at 8:30 a.m.

Alexion Announces Positive Top-Line Results Showing Successful Phase 3 Clinical Study Of ALXN1210 In Complement Inhibitor Treatment-Naïve Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

March 15, 2018 — ALXN1210 Achieved Non-Inferiority to Soliris ® (Eculizumab) on Co-Primary Endpoints of Transfusion Avoidance and Lactate Dehydrogenase Normalization, and All Four Key Secondary Endpoints — — Safety Profile of ALXN1210 Consistent with That Seen for Soliris ® — — Regulatory Submissions

The Manton Center At Boston Children’s Hospital And Alexion Pharmaceuticals Partner In Artificial Intelligence Approaches To Rare Disease Diagnosis

February 27, 2018 BOSTON & NEW HAVEN, Conn.–(BUSINESS WIRE)–The Manton Center for Orphan Disease Research, the Innovation and Digital Health Accelerator at Boston Children’s Hospital, and Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced a collaboration to enable rapid and precise diagnoses

Data Presented At WORLDSymposium™ 2018 Show Survival To 3 Years Of Age And Improvements In Liver Function In Infants With Lysosomal Acid Lipase Deficiency Treated With Kanuma® (Sebelipase Alfa)

February 6, 2018 NEW HAVEN, Conn.–(BUSINESS WIRE)–Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the combined interim data from two ongoing open-label studies, VITAL and CL-08, show a 3-year survival estimate of 68% in infants with rapidly progressive lysosomal acid lipase